Hexarelin
Also known as: Examorelin, HEX
Buy in shop
Hexarelin from $86/kit
2 verified vendors, ≥99% purity, COAs included.
Key Facts: Hexarelin
- Category
- Growth Hormone
- FDA Status
- Not FDA Approved
- Clinical Status
- Investigational - Clinical trials conducted
- Administration
- Subcutaneous injection
- Typical Dose
- 100-200 mcg 2-3x daily
- Frequency
- 2-3x daily
- Duration
- 4-8 weeks (desensitization occurs)
Mechanism of Action
Hexarelin activates ghrelin receptors (GHSR-1a) causing potent GH release. Uniquely, it also binds to CD36 receptors in cardiac tissue, providing cardioprotective effects independent of GH. Causes significant cortisol and prolactin elevation.
Research Summary
Studies show the highest GH release among GHRPs but with desensitization over time. Cardiac research demonstrates protection against ischemia and improved heart function. Used in GH deficiency diagnosis due to reliable GH stimulation.
Dosing Information
Typical Dosingⓘ
Community experience
100-200 mcg 2-3x daily
100-300 mcg per dose
2-3x daily
Most potent GHRP for GH release but causes more desensitization. Usually cycled 4 weeks on, 4 weeks off.
Research Dosingⓘ
Scientific studies
Doses from research studies
Doses from Studies
100-200 mcg per injection
Duration
4-8 weeks (desensitization occurs)
Administration
Subcutaneous injection
Timing & Administration
Best Time to Take
Morning and before bed (fasted)
2-3 times daily, always fasted
Food Recommendation
Take on empty stomach
Why This Timing?
Hexarelin requires fasted state for optimal GH release. Split dosing maximizes GH pulses throughout the day.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Increased appetite
- ●Water retention
- ●Tingling/numbness
- ●Elevated cortisol and prolactin
- ●Flushing
- ●Headache
- ●May trigger histamine release - use caution with MCAS or histamine sensitivity
- ●Receptor desensitization with continuous use
References
- https://pubmed.ncbi.nlm.nih.gov/25278975/
- https://pubmed.ncbi.nlm.nih.gov/10614623/
- https://pubmed.ncbi.nlm.nih.gov/28321024/
Research This Peptide Further
Buy in shop
Hexarelin from $86/kit
2 verified vendors, ≥99% purity, COAs included.
Frequently Asked Questions
What does Hexarelin do?
A synthetic hexapeptide GH secretagogue with the strongest GH-releasing effect among GHRPs. Also has notable cardioprotective properties independent of GH release.
How does Hexarelin work?
Hexarelin activates ghrelin receptors (GHSR-1a) causing potent GH release. Uniquely, it also binds to CD36 receptors in cardiac tissue, providing cardioprotective effects independent of GH. Causes significant cortisol and prolactin elevation.
Is Hexarelin FDA approved?
No, Hexarelin is not currently FDA approved. Current status: Investigational - Clinical trials conducted
What are the side effects of Hexarelin?
Reported side effects include: Increased appetite, Water retention, Tingling/numbness, Elevated cortisol and prolactin, Flushing. Individual responses vary based on dosage, duration, and personal health factors.
What is the typical dose of Hexarelin?
Community-reported common dose: 100-200 mcg 2-3x daily (2-3x daily). Range: 100-300 mcg per dose. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.
Related Peptides
Peptides commonly compared with Hexarelin or used in similar applications.
Ipamorelin
Clinical TrialsA selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.
Growth HormoneMK-677
Clinical TrialsAn orally active growth hormone secretagogue that mimics ghrelin. Although technically not a peptide, it is frequently discussed alongside GH peptides due to similar effects.
Growth HormoneCJC-1295 (No DAC)
Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH release from the pituitary. Often combined with a GHRP like Ipamorelin for synergistic effects.
Growth HormoneTesamorelin
FDAAn FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. New F8 formulation (Egrifta WR) approved March 2025 allows weekly reconstitution vs daily.
Growth HormoneGHRP-6
Clinical TrialsOne of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.
Growth HormoneGHRP-2
Clinical TrialsA synthetic hexapeptide that potently stimulates GH release. More potent than GHRP-6 with less appetite stimulation, but still elevates cortisol and prolactin.
Growth HormoneWant updates on Hexarelin research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.